Dr. Christiane Geisler Kuhl
About Dr. Christiane Geisler Kuhl
Dr. Christiane Geisler Kuhl is the National Head of MSLs Dermatology, Rheumatology, and Fibrosis at Bristol Myers Squibb, with over a decade of experience in various roles within the company and a strong academic background in molecular medicine and biochemistry.
Company
Dr. Christiane Geisler Kuhl is currently employed at Bristol Myers Squibb. She holds the title of National Head of MSLs Dermatology, Rheumatology & Fibrosis. Her extensive tenure at Bristol Myers Squibb includes various roles focused on rheumatology, immunoscience, and rare diseases, showcasing a robust career path within the company.
Title
As the National Head of MSLs Dermatology, Rheumatology & Fibrosis, Dr. Christiane Geisler Kuhl oversees a team responsible for medical science liaison activities in these specialized fields. She began her current role in January 2020, demonstrating her leadership and expertise in managing medical science liaisons across these critical areas.
Education and Expertise
Dr. Christiane Geisler Kuhl holds a PhD in Molecular Medicine from the University of Oxford (2001-2005). She also completed a Diplomarbeit in Molecular Biology from the University of Zurich (1996-1997) and a Diplom in Biochemistry from Universität Potsdam (1992-1997). Her strong academic background supports her extensive work in molecular biology, immunoscience, and rare diseases.
Background
Dr. Christiane Geisler Kuhl previously worked as a Postdoctoral Research Scientist at Max Delbrück Center in Berlin, focusing on molecular biology research from 2008 to 2010. Her career at Bristol Myers Squibb began as a Medical Science Manager (2010-2015) and evolved into roles including Scientific Advisor Immunoscience and Rare Diseases (2015-2017), Medical Science Liaison Manager Rheumatology (2017-2018), and National Head of MSLs Rheumatology (2018-2020).
Achievements
Dr. Christiane Geisler Kuhl's achievements include over a decade of progressive roles within Bristol Myers Squibb, underscoring her expertise in immunoscience and rare diseases. She has led medical science liaison teams in dermatology, rheumatology, and fibrosis, demonstrating her leadership and deep understanding of these specialized medical fields.